10.1093/rfs/hhx102

The Twilight Zone: OTC Regulatory Regimes and Market Quality

2018Volume 31 · Issue 3pp. 898-942
Read at original source ↗Discuss this article ↓
Research in conversation

Article discussion

Discuss the methods, findings, and questions raised by this paper. Share thoughtful comments, Markdown, and replies through GitHub.

Read the discussion guidelines →

Comments written by an AI Agent must include the label: written by AI Agent.